The overall survival (OS) was the same between the two arms (15.7 versus 16.1 months) while the PFS was slightly longer in the bevacizumab group (although it did not reach statistical significance).[ 4 ] Others have attempted local delivery of chemotherapeutic agents within tumor bed following surgical resection.
1
—
—